baber/WOPTO huggingface dataset:
Patent JP-3491167-B2 (JP)
IPC: F16J15/12
Filed: 1993-11-02
Granted: 2004-01-26
Abstract: A restraining element for preventing separation of telescoped pipes (2,4) comprising a compressible body of elastomeric material, said compressible body having metal segments (34) spaced equidistantly around an exposed face of the body, each of the metal segments (34) having a first exposed face with a row of teeth (36,38,40,42), at least four teeth of said row of teeth lying in an arc (56), and at least some of said metal segments (34) having a single tooth (44) extending radially outwardly beyond the face of the metal segment (34) opposite said first exposed face. <IMAGE>
Patent JP-3680590-B2 (JP)
IPC: G02B5/18
Filed: 1998-10-26
Granted: 2005-08-10
Abstract: PROBLEM TO BE SOLVED: To make the cell shape arbitrary, to facilitate the genuine/false judgement, and to improve the decorativeness and security by providing a part where cells in shapes which are meaningful individually like characters, numbers, symbols, etc., are arranged. SOLUTION: The pattern which is constituted by arranging fine cells formed of diffraction gratings on the surface of a substrate and varies in one of the spatial frequency, direction of the diffraction gratings, and arrangement of the cells has a part where the cells in shapes which are meaningful individually like character data (characters, numbers, symbols) are arranged. The figures conceptually show the state wherein original image data are replaced with the cell shape taking the luminance values of respective pixels into consideration by being converted according to an arbitrary rule (f). Even if the original image data are recognized widely by the public and easily obtainable, image manufacture after conversion becomes difficult on condition that the conversion function (f) is not open to the public.
Patent JP-H0637665-B2 (JP)
IPC: C21D1/60
Filed: 1988-12-15
Abstract: Process for modifying the cooling power of an aqueous solution of at least one water-soluble organic polymer which has a lower critical solubility temperature (LCST) with a view to its use for quenching metal alloys, characterised in that a water-soluble additive which modifies the said critical temperature is introduced into the said solution. To lower the LCST of the solution, an inorganic salt of an inorganic or organic acid is preferably employed as an additive in a concentration of between 0.1 and 200 grams per litre, this salt being chosen from the salts of alkali and alkaline-earth metals, including magnesium and zinc. To raise the LCST of the solution, a water-soluble organic derivative is added, in a concentration of between 0.1 and 200 grams per litre, chosen from aliphatic compounds containing at least one functional group chosen from alcohols, acids, aldehydes, amides and amines. <IMAGE>
Patent JP-2963476-B2 (JP)
IPC: A61K31/445
Filed: 1989-12-15
Granted: 1999-10-18
Abstract: A method for the inhibition of tumor metastases is described herein. The method makes use of the administration of certain castanospermine esters or their pharmaceutically acceptable salts.
Patent JP-4079489-B2 (JP)
IPC: G08G1/0968
Filed: 1997-10-27
Granted: 2008-04-23
Abstract: An improved method and system for storage of geographic data on physical storage media. The geographic data are stored in a manner that facilitates and enhances use and access of the data by various navigation application functions in navigation systems that use the data. The geographic data includes a parcelization that separates the geographic data into parcels having less than or equal to a maximum parcel size but having at least a desired fill percentage. The parcelization method also provides for a division arrangement that facilitates addressing and identification of the parcels. According to a further aspect, the geographic data includes special nodal entities that are used to collapse complex intersections, such as roundabouts, cloverleaves, and divided highways, into simpler data representations. The special nodal entities are associated with road segment data entities and used in a route calculation program in place of regular node entities. Further, the geographic data include a normalized attribute array that includes reoccurring combinations of certain selected attributes of the geographic data. Indices to the array are included in place of data corresponding to the selected attributes When a navigation application program requests data, an entry in the normalized attribute table pointed to by an index in the data is used to return the requested data in the particular combination of attributes from the normalized attribute array. The geographic data is compiled by a method that facilitates access to the data on a physical medium. According to the compilation method, data files to be stored on the medium are organized into parcels. The data records within the data files are identified by the parcel in which they are located. An arrangement of all the data files on the medium is determined and a parcel identification related to the medium is assigned to each parcel. Cross references between data records are updated to include the assigned parcel identifications and the parcels are stored on the medium.
Patent JP-3100979-B2 (JP)
IPC: C25B9/19
Filed: 1990-11-06
Granted: 2000-10-23
Abstract: The invention is a ceramic solid electrolyte based electrochemical oxygen concentrator cell and the method for fabricating said cell. The cell is based on a doped cerium oxide ceramic solid electrolyte and lanthanum strontium cobaltite ceramic electrodes.
Patent JP-H0622704-B2 (JP)
IPC: B04B5/12
Filed: 1986-05-28
Abstract: A disposable diagnostic plasma filter dispenser includes a low cost disposable container and a rotor drive for rotationally energizing a rotor within the container. The disposable container is particularly suitable for drawing and dispensing blood samples for clinical analysis and includes a tube shaped outer wall having a frangible dispenser outlet cover, a close fitting inner tube supporting a filter membrane and a unitary rotor disposed for axel free rotation and axial translation within the inner tube in response to energization from the rotor driver. The rotor produces vortex enhanced filtration while maintaining a flow of filter fluid through the filtration gap and creating a transmembrane pressure.
Patent JP-2759652-B2 (JP)
IPC: C07K1/26
Filed: 1987-08-07
Granted: 1998-05-28
Abstract: The protein doublet H110D, the individual components thereof, and the production and use thereof in a vaccine against a nematode infection. This protein doublet is a plasma membrane-associated protein material of the intestinal microvilli of Haemonchus contortus. H110D has a molecular weight of about 110 kd and reacts with antibodies raised in animals injected with a contortin-enriched fraction. Injection of preparations of the protein doublet H110D or its components induces the production of specific protective antibodies.
Patent JP-3088746-B2 (JP)
IPC: A61M27/00
Filed: 1991-05-31
Granted: 2000-09-18
Abstract: An implant for use in the treatment of glaucoma is disclosed wherein the implant comprises an elastomeric plate having a non-valved elastomeric drainage tube attached thereto. The plate is elliptical in-shape and curved so as to conform to the curvature of the eye. The plate is inserted into the eye in an incision made in the Tenon's capsule and sutured to the sclera. The drainage tube is tunnelled through the Tenon's capsule and cornea and inserted into the anterior chamber, thus providing patent fluid communication between the anterior chamber and the elastomeric plate. The flexible structure of the plate allows the plate to be easily inserted, thus reducing the surgical procedure length. In addition, the pliable material minimizes the risk of damage and trauma to surrounding tissues in the insertion process.
Patent JP-3497507-B2 (JP)
IPC: C08J7/04
Filed: 1993-12-06
Granted: 2004-02-16
Abstract: PCT No. PCT/AT93/00185 Sec. 371 Date May 31, 1995 Sec. 102(e) Date May 31, 1995 PCT Filed Dec. 6, 1993 PCT Pub. No. WO94/13734 PCT Pub. Date Jun. 23, 1994This invention relates to a process applying a water-repellent and/or waterproof coating to at least one side or the inside of shaped elements, which are obtained in that starch-containing compositions are baked between two mould halves or are extruded. That process is characterized in that a lacquer which in addition to one or more low-boiling solvents which are miscible with water and are innocuous from the aspect of human and/or ecotoxicology and one or more rottable film-forming substances and one or more rottable hydrophobic plasticizers is applied and during the application of said lacquer the adsorbed water of hydration is removed from the surface layer of the shaped element which is to be coated, whereafter the solvent mixture is removed which a minimum moisture content from 5% by weight to one at which there is no odour maintained in the substrate. Suitable film-forming substances include alkyl celluloses and non-hydrophobic water-insoluble cellulose esters of the group consisting of cellulose acetate butyrates, cellulose acetate propionates and cellulose acetates. Suitable plasticizers include hydrophobic triglycerides of fatty acids having medium and long chain lengths (chain lengths larger than or equal to C4), triglycerides partly substituted with substituents having shorter chain lengths, and, provided that at least one fatty acid having a chain length larger than or equal to C14 is contained, phthalic acid esters, acylic dicarboxylic acid esters, fully esterified citric acid esters, saccharose acetate isobutyrate and other hydrophobic sugar esters.
Patent JP-4139440-B2 (JP)
IPC: A61K49/00
Filed: 1997-08-26
Granted: 2008-08-27
Abstract: A method for providing an image of an internal region of a patient has been developed. The method reduces imaging artifacts by providing enhanced contrast between tissue and blood during imaging. The method comprises administering to a patient a contrast agent in combination with a renal vasodilator and performing ultrasound imaging of the region. Renal disease, including renal arterial stenosis, may be diagnosed using the method.
Patent JP-3507497-B2 (JP)
IPC: A61P35/02
Filed: 1993-12-15
Granted: 2004-03-15
Abstract: The present invention relates to the compounds of formula (I)    <IMAGE>  (I)  wherein one of the groups X1 to X4 is N and the others are CH; the rest of the variables are as defined in the specification.
Patent JP-3109524-B2 (JP)
IPC: F23H11/12
Filed: 1995-11-15
Granted: 2000-11-20
Abstract: PCT No. PCT/EP95/04495 Sec. 371 Date Jun. 11, 1996 Sec. 102(e) Date Jun. 11, 1996 PCT Filed Nov. 15, 1995 PCT Pub. No. WO96/16306 PCT Pub. Date May 30, 1996This invention concerns a grate plate arrangement for step grates wherein a plurality of grate plates (2) can be laid side-by-side on to a grate carrier (2) and can each be fixed to the grate carrier by means of a respective clamping device (11) which engages the grate plate and the grate carrier. In this arrangement, the clamping device (11) includes at least one clamping element (12) whose end (14), which is towards the grate plate, engages through an opening (15) in a front end wall (3) of the grate plate (2). The clamping device has clamping means (16) which are actuable from the front end wall side. The other clamping element end, which is towards the grate carrier, is provided with anchoring means (13) for force-transmitting connection to the grate carrier. This arrangement makes it possible for the grate plates to be mounted or dismantled from the top side of the grate, so that the mounting operation can be performed in a more rational fashion and in a better manner from the point of view of maintenance, and industrial health and safety standards.
Patent JP-2593993-B2 (JP)
IPC: C08F26/10
Filed: 1991-10-29
Granted: 1997-03-26
Abstract: Cross-linked copolymers which are obtainable by polymerizing a neutral diluent monomer or monomers, a monomer or monomers bearing a center of permanent positive charge, and a bifunctional and/or trifunctional cross-linking agent, are suitable for use in contact lenses. Process for producing them by copolymerization, contact lens material comprising them, contact lenses made of them and processes for producing contact lenses from them.
Patent JP-2857253-B2 (JP)
IPC: H04L13/00
Filed: 1994-12-19
Granted: 1999-02-17
Abstract: This invention consists of an ophthalmic storage and dispensing device formed by injection molding, consisting of a vial with thick rigid walls and a limited flexible area. The flexible area allows only a small displacement when squeezed providing a metered volume of dispensed liquid. It also has an integral molded dropper tip as well as an integral molded puncture membrane within the tip. A bottom plug, which serves as closure after filling, is sealed to the vial. The bottom plug is of varying size and shape so as to provide for varying internal liquid capacity in the same bottle. It can also have a separate cap which acts as both a seal break and reclosable mechanical liquid seal between usage periods. Both vial and cap offer a geometric shape which facilitates gripping and limits rolling.
Patent JP-4082733-B2 (JP)
IPC: C12P21/08
Filed: 1997-02-06
Granted: 2008-04-30
Abstract: 2F1 polypeptides are provided, along with DNA sequences, expression vectors and transformed host cells useful in producing the polypeptides. Soluble 2F1 polypeptides find use in inhibiting prostaglandin synthesis and treating inflammation.
Patent JP-3958362-B2 (JP)
IPC: A61K38/00
Filed: 1996-04-19
Granted: 2007-08-15
Abstract: A method and compounds are provided for inhibiting the synthesis of extracellular matrix proteins. Compounds of the invention comprise oligonucleotides specific for nuclear proto-oncogenes. Preferably, oligonucleotides of the invention are selected from the group consisting of c-myc and c-myb and are locally administered. The invention finds use in the treatment of a variety of disorders, including sclerotic disorders and restenosis, associated with the inappropriate synthesis of extracellular matrix proteins, particularly collagen.
Patent MD-3119-B2 (MD)
Title: Drug form for oral use with prolonged release of molsidomine
Inventor: GECZY JOZSEF-MICHEL
IPC: A61K9/22
Filed: 2001-02-22
Abstract: The present invention relates to a novel sustained-release oral galenical form of molsidomine for the treatment of all forms of angina attack (angina of effort, spastic angina, mixed angina). According to the invention, this novel galenical form contains a therapeutically effective amount of molsidomine or one of its active metabolites and has an in vitro dissolution rate [measured spectrophotometrically at 286 or 311 nm by the method described in the European Pharmacopoeia, 3rd edition (or USP XXIV), at 50 rpm, in 500 ml of a 0.1 N HCl medium, at 37° C.] of: 15 to 25% of molsidomine released after 1 hour, 20 to 35% of molsidomine released after 2 hours, 50 to 65% of molsidomine released after 6 hours, 75 to 95% of molsidomine released after 12 hours, >85% of molsidomine released after 18 hours and >90% of molsidomine released after 24 hours, the plasma peak of molsidomine obtained in vivo occurring 2.5 to 5 hours, preferably 3 to 4 hours, following the administration of said form, and having a value of between 25 and 40 ng/ml of plasma. Application: therapeutics industry.
Patent ES-2363546-B2 (ES)
Title: "método de diseño geométrico de mallas espaciales, perteneciente al campo de la arquitectura e ingenieria civil, mediante superficies nurbs".
Inventor: ARIAS FERNANDEZ RUBEN
IPC: E04B1/19
Filed: 2011-03-28
Granted: 2012-02-22
Abstract: Método de diseño geométrico de mallas espaciales
mediante superficies NURBS. 
     Un método para obtener un diseño de la geometría
de una malla espacial formada por una pluralidad L de entidades
lineales l', caracterizado porque comprende las etapas de: elegir
tres puntos (C_{00} C_{0n} C_{n0}) en un plano que define un
triángulo; elegir un punto (O) ajeno a ese plano; elegir un orden de
complejidad n, donde n es un número natural mayor o igual que 1;
calcular un conjunto de puntos de control C_{ij} en dicho
triángulo que dependen de n y de los tres puntos elegidos (C_{00}
C_{0n} C_{n0}); elegir unos pesos \lambda_{ij}, donde cada uno
de estos pesos se relaciona con un punto de control C_{ij};
transformar el conjunto de puntos de control C_{ij} en una
pluralidad de puntos P_{ij} que definen un poliedro de control;
obtener una superficie NURBS a partir de dicho poliedro de control;
dentro del plano definido por dichos puntos (C_{00} C_{0n}
C_{n0}), definir un entramado como una pluralidad L de lados l';
transformar dicha pluralidad L de lados l en una pluralidad de
entidades lineales l' constitutivas de dicha malla espacial.
Estructura mallada. Programa informático.
Patent ES-2547582-B2 (ES)
Title: Método para la valoración de riesgo cardiovascular no clásico mediante la detección de autoanticuerpos anti-lipoproteínas de alta densidad, inmunosensor y kit para su aplicación
Inventor: SUAREZ DIAZ ANA
IPC: G01N33/49
Filed: 2015-04-30
Granted: 2016-05-05
Abstract: Método para la valoración de riesgo cardiovascular no clásico mediante la detección de autoanticuerpos anti-lipoproteínas de alta densidad, inmunosensor y kit para su aplicación. El método comprende poner en contacto una muestra del sujeto con partículas de HDL humanas en condiciones tales que pueda producirse una unión específica antígeno-anticuerpo detectable, y estratificar el riesgo cardiovascular del sujeto comparando el resultado obtenido en el análisis de la muestra con los obtenidos en la población sana.#La invención resulta de aplicación en los sectores de la biotecnología y la farmacia y en el de la medicina y el diagnóstico clínico, y más concretamente en la valoración de riesgo cardiovascular para prevenir enfermedades mediante el uso de biomarcadores en diferentes grupos de pacientes.
Patent ES-2632107-B2 (ES)
Title: Material microcompuesto magnético permanente sin tierras raras y su método de obtención.
Inventor: ARAGON SANCHEZ ANA MARÍA
IPC: H01F1/047
Filed: 2016-02-08
Granted: 2018-01-15
Abstract: Material microcompuesto magnético permanente sin tierras raras y su método de obtención.#Se reivindica un material microcompuesto basado en imanes permanentes compuestos de partículas cerámicas de ferrita hexagonal magnéticamente duras y partículas de aleaciones metálicas magnéticamente blandas y su método de fabricación por aleado mecánico en presencia de un agente de acoplamiento.#Los imanes permanentes sin tierras raras basados en nanopartículas presentan un método de producción industrial complejo y costoso. La invención describe la obtención un material composite basado en ferritas y aleaciones metálicas de tamaño micrométrico (no-nanométrico), mediante métodos de molienda mecánica. Se consigue un producto mediante un método de fabricación fácilmente escalable, industrializable y de bajo coste, con el que se obtienen materiales compuestos con propiedades magnéticas y microestructurales favorables caracterizados por presentar un aumento del producto máximo de energía (BHmax) de hasta un 30% respecto al componente mayoritario de ferrita.
Patent AU-2001237556-B2 (AU)
Title: 1,5-benzothiazepines and their use as hypolipidaemics
Inventor: STARKE INGEMAR
IPC: C07D281/10
Filed: 2001-03-05
Granted: 2004-10-07
Abstract: The present invention relates to compounds of formula (I) wherein R<SUP>1 </SUP>and R<SUP>2 </SUP>are independently selected from C<SUB>1-6</SUB>alkyl; one of R<SUP>4 </SUP>and R<SUP>5 </SUP>is a group of formula (IA): R<SUP>3</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP>, R<SUP>8</SUP>, R<SUP>9</SUP>, R<SUP>10 </SUP>and R<SUP>11 </SUP>and the other of R<SUP>4 </SUP>and R<SUP>5 </SUP>are as defined within, pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and there use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
Patent AU-2002319202-B2 (AU)
Title: Method and device for suppressing electromagnetic background radiation in an image
Inventor: KIRSSCHNER HOLGER
IPC: G01B11/00
Filed: 2002-06-07
Granted: 2007-05-24
Abstract: The method involves recording at least one P-image (A) for a defined spectral range, and recording at least one N-image (B) for a different defined spectral range. A signal and information processing device uses a model of the spectral distribution of the background radiation (2) to determine the image brightness (SSP) of the background radiation in at least one P-image, and the signal to be detected is extracted. Independent claims are also included for an apparatus for suppressing EM background radiation, and for a measuring device for geodetic measurements.
Patent AU-2002340817-B2 (AU)
Title: Ready to bake dough with shaped, coextruded filling and method of making same
Inventor: YOAKUM JERRY
IPC: A21D6/00
Filed: 2002-08-14
Granted: 2008-09-04
Abstract: A ready to bake dough product with a shaped filling is disclosed. The filling is sized and configured so as to minimize or avoid exposure or spilling during processing, handling, or baking. The shape of the filling is configured such that it has a shorter distance vertically than horizontally. The shape of the filling may be substantially in the form of a rectangle, triangle, pentagon, hexagon, half circle, diamond, trapezoid, oval, or similar shapes.
Patent AU-2002352216-B2 (AU)
Title: Coating method and coating
Inventor: HAUSER KARL
IPC: C03C17/245
Filed: 2002-12-04
Granted: 2007-10-11
Abstract: The invention relates to a method for applying one or several coats to a substrate in a device comprising a PVD/CVD coating chamber. One solid matter is physically transformed at least in part into a gaseous phase and is applied to the substrate in the gaseous phase. At least one additional compound and/or one additional metal is added to the gaseous phase in liquid or gaseous form, and the at least one additional compound and/or the at least one additional metal reacts with the surface of the substrate. The invention also relates to a coating that is produced according to said method.
Patent AU-2002367029-B2 (AU)
Title: Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
Inventor: KETELSON HOWARD ALLEN
IPC: A61F/
Filed: 2002-12-20
Granted: 2008-10-02
Abstract: The use of nanoparticles of inorganic materials (e.g., synthetic smectite clays) in ophthalmic and otic pharmaceutical compositions is described. The nanoparticles are utilized as biologically inert carriers or depots for ophthalmic and otic drugs. The nanoparticles may also be utilized to modify the rheological properties of the compositions, so as to enhance the viscosity or flow characteristics of the compositions and/or increase the retention time of the compositions in the eye or ear.
Patent AU-2003243348-B2 (AU)
Title: Universal biosensor and methods of use
Inventor: BAEUMNER ANTJE J
IPC: G01N33/543
Filed: 2003-05-30
Granted: 2009-12-03
Abstract: The present invention relates to methods for detecting or quantifying an analyte in a test sample including providing at least one test mixture including a test sample, at least one marker complex, wherein each marker complex includes a particle, a marker, and one member of a coupling group, a first binding material selected to bind to a portion of the analyte, a second binding material selected to bind with a portion of the analyte other than the portion of the analyte for which the first binding material is selected, analyte analog, and/or marker conjugate. The at least one test mixture is passed through a membrane. The amount of marker on the membrane is detected and correlated to the presence or amount of analyte in the test sample.